- Home
- ARDX vs RDFN Comparison
ARDX vs RDFN Comparison
Compare ARDX & RDFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- RDFN
- Stock Information
- Founded
- ARDX 2007
- RDFN 2002
- Country
- ARDX United States
- RDFN United States
- Employees
- ARDX N/A
- RDFN N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- RDFN Real Estate
- Sector
- ARDX Health Care
- RDFN Finance
- Exchange
- ARDX Nasdaq
- RDFN Nasdaq
- Market Cap
- ARDX 1.3B
- RDFN 1.2B
- IPO Year
- ARDX 2014
- RDFN 2017
- Fundamental
- Price
- ARDX $3.64
- RDFN $9.06
- Analyst Decision
- ARDX Strong Buy
- RDFN Hold
- Analyst Count
- ARDX 8
- RDFN 11
- Target Price
- ARDX $10.19
- RDFN $10.85
- AVG Volume (30 Days)
- ARDX 6.4M
- RDFN 5.9M
- Earning Date
- ARDX 05-01-2025
- RDFN 05-06-2025
- Dividend Yield
- ARDX N/A
- RDFN N/A
- EPS Growth
- ARDX N/A
- RDFN N/A
- EPS
- ARDX N/A
- RDFN N/A
- Revenue
- ARDX $361,706,000.00
- RDFN $1,038,527,000.00
- Revenue This Year
- ARDX $15.74
- RDFN $0.39
- Revenue Next Year
- ARDX $34.56
- RDFN $5.92
- P/E Ratio
- ARDX N/A
- RDFN N/A
- Revenue Growth
- ARDX 127.33
- RDFN 5.11
- 52 Week Low
- ARDX $3.62
- RDFN $5.49
- 52 Week High
- ARDX $9.20
- RDFN $15.29
- Technical
- Relative Strength Index (RSI)
- ARDX 32.40
- RDFN 48.34
- Support Level
- ARDX $3.62
- RDFN $8.80
- Resistance Level
- ARDX $5.65
- RDFN $9.78
- Average True Range (ATR)
- ARDX 0.31
- RDFN 0.45
- MACD
- ARDX -0.15
- RDFN 0.02
- Stochastic Oscillator
- ARDX 6.53
- RDFN 56.89
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
About RDFN Redfin Corporation
Redfin Corp is a residential real estate broker. It pairs its agents with the technology to create a service that is faster and costs less. The company meets customers through a listings-search website and mobile application. The company uses the same combination of technology and local service to originate mortgage loans and offer title and settlement services. It has five operating segments real estate services, rentals, mortgage, title, and monetization. The company generates the majority of its revenue from Real estate services.